Data from a pilot study published in Catheterization and Cardiovascular Interventions suggest renal denervation is safe and effective for treatment of mild resistant hypertension, findings that "[expand] the potential boundaries for renal denervation," according to an accompanying editorial by SCAI fellow Dr. Deepak Bhatt. No adverse events were documented in the study of 20 patients, while four were able to scale back antihypertensive therapies by the three-month follow-up.

Related Summaries